LOSS PER SHARE (Tables)

3 Months Ended

12 Months Ended

May 31, 2026

Feb. 28, 2026

Earnings Per Share [Abstract]

SCHEDULE OF NET INCOME (LOSS) PER COMMON SHARE

The net income (loss) per common share amounts were determined as follows:

		May 31, 2026				May 31, 2025
		For the Three Months Ended
		May 31, 2026				May 31, 2025
Numerator:
Net loss available to common shareholders		$	(5,715,838	)		$	(4,594,018	)

Effect of common stock equivalents
Less: dividends to C preferred shareholders			(110,860	)			(12,073	)
Net loss adjusted for common stock equivalents			(5,826,698	)			(4,606,091	)

Denominator:
Weighted average shares – basic			325,956,059				155,176,712

Net loss per share – basic		$	(0.02	)		$	(0.03	)

Denominator:
Weighted average shares – diluted			325,956,059				155,176,712

Net loss per share – diluted		$	(0.02	)		$	(0.03	)

The net loss per common share amounts were determined as follows:

		2026				2025
		For the Year Ended
		February 28,				February 28,
		2026				2025
Numerator:
Net loss available to common shareholders		$	(14,510,251	)		$	(18,935,592	)

Effect of common stock equivalents
Less redemption dividend to Series F and Series B preferred shareholders			(114,561	)			(423,476	)
Net loss adjusted for common stock equivalents			(14,624,812	)			(19,358,968	)

Denominator:
Weighted average shares - basic			202,908,578				116,476,733

Net loss per share – basic		$	(0.07	)		$	(0.16	)

Denominator:
Weighted average shares – diluted			202,908,578				116,476,733

Net loss per share – diluted		$	(0.07	)		$	(0.16	)

SCHEDULE OF ANTI-DILUTIVE SHARES OF COMMON STOCK EQUIVALENTS

The anti-dilutive shares of common stock equivalents for the three months ended May 31, 2026 and 2025 were as follows:

		May 31, 2026				May 31, 2025
		For the Three Months Ended
		May 31, 2026				May 31, 2025
Convertible or exchangeable debt			3,173,350,733				-
Convertible Series F Preferred Shares			1,340,264,933				586,412,155
Convertible Redeemable Series C Preferred Shares			30,948,471				2,958,264
Stock options and warrants			2,202,121				2,261,775
Total			4,546,766,258				591,632,194

The anti-dilutive shares of common stock equivalents for the years ended February 28, 2026 and February 28, 2025 were as follows:

		2026				2025
		For the Year Ended
		February 28,				February 28,
		2026				2025
Convertible Series F Preferred Shares			924,161,175				497,229,655
Convertible Series C Preferred Shares			22,830,847				1,718,308
Convertible and exchangeable debt			1,095,380,027				—
Stock options and warrants			2,202,121				2,294,996
Total			2,044,574,170				501,242,959